0,1,2,3,4,5,6
358,,,,,Clin J Gastroenterol,(2014) 7:355â€“360
Table 1 Laboratory data before,,,,,,
,WBC,3100/ll,c-GTP,33 IU/l,KL-6,485 U/ml
second interferon-b treatment,,,,,,
,Hb,13.1 g/dl,TP,8.1 g/dl,SP-D,94.8 ng/ml
,Hct,38.6 %,ALB,4.0 g/dl,ANA,\40
,Plt,10.5 9 104/ll,TC,136 mg/dl,,
,PT,94.0 %,UA,5.3 mg/dl,HCV,
,T-Bil,0.7 mg/dl,UN,15.9 mg/dl,Genotype,1b
,D-Bil,0.3 mg/dl,Cre,0.68 mg/dl,RNA load,5.2 LogIU/ml
,AST,47 IU/l,Glucose,96 mg/dl,ISDR,"Mixed type (0, 1, 4)"
,ALT,45 IU/l,HbA1c,4.9 %,Core 70AA,Wild type
,LDH,164 IU/l,AFP,18.5 ng/ml,Core 91AA,Wild type
"KL-6 normal value \500 U/ml,",,,,,,
,ALP,288 IU/l,PIVKA II,16 mAU/ml,IL28B rs8099917,T/T
SP-D normal value \110 ng/ml,,,,,,
